HP
LRMR icon

Hikari Power’s Larimar Therapeutics LRMR Stock Holding History

Hikari Power’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,500
Closed -$116K – 70
2020
Q1 		$116K Sell
12,500
-4,218
-25% -$55.5K 0.02% 76
2019
Q4 		$223K Hold
16,718
– – 0.02% 89
2019
Q3 		$148K Buy
16,718
+4,175
+33% +$45.8K 0.02% 113
2019
Q2 		$179K Hold
12,543
– – 0.02% 109
2019
Q1 		$412K Buy
12,543
+1,750
+16% +$89.7K 0.04% 78
2018
Q4 		$641K Buy
+10,793
New +$1.07M 0.07% 67

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Hikari Power's LRMR Position: Q2 2020 in Review

Hikari Power sold out of Larimar Therapeutics (LRMR) in Q2 2020, closing a stake of 12,500 shares — an estimated $116K sold.

Hikari Power first reported a position in LRMR in Q4 2018 and held it in 6 quarters. The position peaked at $641K in Q4 2018. 37 funds tracked by Wall St. Rank hold LRMR as of Q2 2020.

  • Hikari Power reported no remaining Larimar Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Hikari Power sold 12,500 Larimar Therapeutics shares in Q2 2020, an estimated $116K.
  • Hikari Power first reported a position in Larimar Therapeutics in Q4 2018 and held it in 6 quarters.
  • Hikari Power's Larimar Therapeutics position peaked at $641K in Q4 2018.
  • 37 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2020.

Based on Hikari Power's 13F filing for Q2 2020, filed 13 Aug 2020.